89. リンパ脈管筋腫症 Lymphangioleiomyomatosis Clinical trials / Disease details

臨床試験数 : 38 / 薬物数 : 38 - (DrugBank : 15) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 118

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02737202 (ClinicalTrials.gov)	April 2016	31/3/2016	Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis	Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis	Pulmonary Lymphangioleiomyomatosis	Drug: saracatinib	Baylor College of Medicine	University of Cincinnati;Brigham and Women's Hospital;Stanford University;Loyola University;Universi ...	Terminated	18 Years	65 Years	Female	28	Phase 2	United States
2	NCT02116712 (ClinicalTrials.gov)	August 2014	15/4/2014	The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)	The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)	Pulmonary Lymphangioleiomyomatosis	Drug: Saracatinib	Tony Eissa	University of Texas;University of Cincinnati	Completed	18 Years	65 Years	Both	9	Phase 1	United States

First Previous1Next Last